Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Metlife (MET-PF) EBITDA Margin (2016 - 2025)

Metlife has reported EBITDA Margin over the past 17 years, most recently at 13.46% for Q4 2025.

  • Quarterly results put EBITDA Margin at 13.46% for Q4 2025, up 8675.0% from a year ago — trailing twelve months through Dec 2025 was 17.12% (down 1016.0% YoY), and the annual figure for FY2025 was 29.27%, down 1807.0%.
  • EBITDA Margin for Q4 2025 was 13.46% at Metlife, down from 30.21% in the prior quarter.
  • Over the last five years, EBITDA Margin for MET-PF hit a ceiling of 58.25% in Q2 2021 and a floor of 73.29% in Q4 2024.
  • Median EBITDA Margin over the past 5 years was 9.3% (2021), compared with a mean of 2.79%.
  • Biggest five-year swings in EBITDA Margin: plummeted -10447bps in 2022 and later surged 8675bps in 2025.
  • Metlife's EBITDA Margin stood at 42.76% in 2021, then plummeted by -33bps to 28.6% in 2022, then decreased by -1bps to 28.2% in 2023, then crashed by -360bps to 73.29% in 2024, then skyrocketed by 118bps to 13.46% in 2025.
  • The last three reported values for EBITDA Margin were 13.46% (Q4 2025), 30.21% (Q3 2025), and 10.41% (Q2 2025) per Business Quant data.